Skip to main content
. 2022 Jul 20;13(7):629. doi: 10.1038/s41419-022-05071-6

Fig. 1. Identification of HOXA10-AS as a cancer-associated noncoding RNA.

Fig. 1

A Hierarchical clustering analysis of the differentially expressed lncRNAs in tumor tissues (T) and their adjacent normal sections (N) with OSCC sequencing is shown. B A list of the highly differential lncRNAs with their fold changes in expression and corresponding false discovery rate is presented. C HOXA10-AS expression in the paired normal and tumor tissues was measured by RT-qPCR assay and is presented as ΔCt method (n = 18). D Comparative expression profiles of HOXA10-AS transcript across different tumor types from the TCGA dataset are presented. E Kaplan–Meier survival curves of patients stratified according to HOXA10-AS expression are shown. The HOXA10-AS RNA expression of the clinical samples was measured and further ranked to assess the association between expression and the survival rate (n = 115).